Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling-Perry, K., . . . Jüppner, H. (2010). Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active. The Endocrine Society.

Shimada, Takashi, Itaru Urakawa, Tamara Isakova, Yuji Yamazaki, Michael Epstein, Katherine Wesseling-Perry, Myles Wolf, Isidro B. Salusky, a Harald Jüppner. Circulating Fibroblast Growth Factor 23 in Patients With End-Stage Renal Disease Treated By Peritoneal Dialysis Is Intact and Biologically Active. The Endocrine Society, 2010.

Shimada, Takashi, et al. Circulating Fibroblast Growth Factor 23 in Patients With End-Stage Renal Disease Treated By Peritoneal Dialysis Is Intact and Biologically Active. The Endocrine Society, 2010.